Subclassifications Of Assets, Liabilities And Equities [Abstract]

ABIONYX Pharma - Filing #831404

Concept	As at 2023-12-31	As at 2022-12-31
Subclassifications of assets, liabilities and equities [abstract]
Property, plant and equipment [abstract]
Property, plant and equipment	335,000 EUR	373,000 EUR
Intangible assets and goodwill [abstract]
Intangible assets other than goodwill [abstract]
Intangible assets other than goodwill	80,000 EUR	75,000 EUR
Goodwill	5 377 EUR	5 377 EUR
Miscellaneous non-current assets [abstract]
Other non-current assets	276,000 EUR	240,000 EUR
Classes of current inventories [abstract]
Current inventories	221,000 EUR	147,000 EUR
Classes of current inventories, alternative [abstract]
Cash and cash equivalents [abstract]
Cash and cash equivalents	4 104 EUR	4 046 EUR
Miscellaneous current assets [abstract]
Other current assets	1 648 EUR	2 082 EUR
Borrowings [abstract]
Non-current portion of non-current borrowings	1 101 EUR	1 415 EUR
Current borrowings and current portion of non-current borrowings [abstract]
Current borrowings and current portion of non-current borrowings	506,000 EUR	491,000 EUR
Non-current portion of non-current borrowings, by type [abstract]
Current borrowings and current portion of non-current borrowings, by type [abstract]
Trade and other current payables [abstract]
Current trade payables	1 439 EUR	1 853 EUR
Issued capital [abstract]
Issued capital	1 623 EUR	1 418 EUR
Retained earnings [abstract]
Retained earnings, profit (loss) for reporting period	3 518 EUR	4 206 EUR
Accumulated other comprehensive income [abstract]
Reserve of exchange differences on translation	103,000 EUR	126,000 EUR
Net assets (liabilities) [abstract]
Assets	14 834 EUR	15 823 EUR
Net current assets (liabilities) [abstract]
Current assets	6 886 EUR	7 572 EUR
Current liabilities	3 925 EUR	5 094 EUR
Assets less current liabilities [abstract]